Arterys FDA Clearance for Liver AI and Lung AI Lesion Spotting Software
Arterys, a San Francisco, California firm, won FDA clearance for its Arterys Oncology AI suite. The cleared software aids in finding lesions within CT images of the lungs (Lung AI) and in both CT and MRI when assessing the liver (Liver AI). It uses a...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Radiology Source Type: blogs
More News: Cancer | Cancer & Oncology | Cardiology | Heart | HIPAA | HIV AIDS | Legislation | Liver | Liver Transplant | Lung Transplant | Radiology | Urology & Nephrology